Home » Topics » Disease categories and therapies » Immune

Immune
RSS

SmithKline Beecham launches new combined vaccine for hepatitis A and typhoid in the U.K.

June 30, 1999

New hepatitis A vaccine affords protection with first dose

June 30, 1999

Sumitomo presents new inhibitors of STAT6 activation

June 29, 1999

Chimeric Therapies initiates pivotal trial evaluating proprietary method for allogeneic BMT

June 25, 1999

Avant achieves milestone in rotavirus vaccine program with SB

June 25, 1999

AM-6898E: new anti-IgE antibody agent for immune disorders

June 24, 1999

PowderJect and Glaxo Wellcome further expand DNA vaccine alliance

June 24, 1999

Vaccines and vaccine vectors comprising auxotrophic attenuated strains of Listeria

June 18, 1999

Potassium channel-modulating immunosuppressants designed at Merck

June 18, 1999

NIAID sponsors phase III trial of varicella vaccine for prevention of shingles

June 18, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 17, 2026.
Biohaven reports details on discovery of BHV-2100
BioWorld Science
Transient receptor potential melastatin 3 (TRPM3) is a calcium-permeable TRP channel that is highly expressed in somatosensory neurons, including nociceptors of...
New GABA(B) receptor PAMs revealed in Addex Pharma patents
BioWorld Science
Addex Pharma SA has disclosed new GABA(B) receptor positive allosteric modulators (PAMs) potentially useful for the treatment of chronic cough, urinary...
Meta-analysis: Anti-amyloid Alzheimer’s drugs not ‘clinically meaningful’
BioWorld
The ongoing controversy over the effectiveness of anti-amyloid drugs is about to get more heated, after a review of clinical trials showed statistically...
Novel caspase-2 inhibitor shows in vivo neuroprotective effects
BioWorld Science
Caspase-2-mediated cleavage of tau at Asp314 generates a neurotoxic fragment, Δtau314, that drives early synaptic dysfunction in Alzheimer’s disease (AD) and...